Nigel Gilchrist

3.0k citations

70 papers · 2.0k indexed · 1 hit paper · h-index 22

Impact in

Orthopedics and Sports Medicine top 0.5%
- Bone health and osteoporosis research
- Bone and Joint Diseases
Oncology top 5%
- Bone health and treatments

Papers in

Orthopedics and Sports Medicine 28
- Bone health and osteoporosis research 27
- Bone and Joint Diseases 5
Oncology 18
- Bone health and treatments 15

Co-authors: Jacques P. Brown Christian Roux Ove Törring Jens‐Erik Beck Jensen Michael R. McClung Ivo Valter Chris Frampton Steven R. Cummings
Journals: Osteoporosis International (6 papers)The Journal of Clinical Endocrinology & Metabolism (4 papers)Journal of Bone and Mineral Research (3 papers)Bone (2 papers)Journal of Clinical Densitometry (2 papers)
Partner nations: New Zealand United Kingdom United States

In The Last Decade

Nigel Gilchrist

67 papers receiving 1.9k citations

Hit Papers

align trajectories log scale

Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension 2017 · 458 citations

Peers

Countries citing papers authored by Nigel Gilchrist

Since Specialization

Citations

This map shows the geographic impact of Nigel Gilchrist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel Gilchrist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel Gilchrist more than expected).

Fields of papers citing papers by Nigel Gilchrist

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nigel Gilchrist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel Gilchrist. The network helps show where Nigel Gilchrist may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Nigel Gilchrist, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nigel Gilchrist Line = papers co-authored together Nigel Gilchrist links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Perispinal Etanercept to improve STroke Outcomes (PESTO): Protocol for a multicenter, international, randomized placebo-controlled trial European Stroke Journal ·Vincent Thijs, Geoffrey Cloud, Nigel Gilchrist, Brooke Parsons, Hj. Wetter, Jan Hoong Ho, David Tamés, Emanuel Barnoffi, Nikola Sprigg, Marion Walker, Philip M. Bath, Leonid Churilov, Julie Bernhardt	2024	2
2	Extending the safety profile of the post-operative administration of an intravenous acetaminophen/ibuprofen fixed dose combination: An open-label, multi-center, single arm, multiple dose study Biomedicine & Pharmacotherapy ·Dikshita Garg, Nigel Gilchrist, Simon Carson, 小呆, Hartley C. Atkinson	2021	6
3	Enhanced hip fracture management: use of statistical methods and dataset to evaluate a fractured neck of femur fast track pathway-pilot study. PubMed ·Nigel Gilchrist, C.H. ter Kuile, Asit Desai, Gary J. Hooper, Jaime Adrián Millán Leyva, 刘静芬, John McKie, Yi Ma, Sandra Chamberlain, Matt Colours, Ted Engelbart	2017	8
4	A phase 2 study of MK-5442, a calcium-sensing receptor antagonist, in postmenopausal women with osteoporosis after long-term use of oral bisphosphonates Osteoporosis International ·Felicia Cosman, Nigel Gilchrist, Michael R. McClung, J. Földes, H. Finger, Arthur C. Santora, Albert Leung, L.M. Hudson, Norman Heyden, 孝行峯岸, Erwin Rosenberg, Andrew Denker	2015	19
5	Recruitment strategies for an osteoporosis clinical trial: Analysis of effectiveness Australasian Journal on Ageing ·R. Mandryk, MARY LOUISE BUNKER, Patricia A. Maguire, Arzhnikov V.V., Paul Ydaha, George Katsirelos, Christopher Frampton, Gary Nicholls, Nigel Gilchrist	2012	5
6	Discontinuation of denosumab and associated fracture incidence: Analysis from the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) Trial Journal of Bone and Mineral Research ·Jacques P. Brown, Christian Roux, Ove Törring, Pei‐Ran Ho, Jens‐Erik Beck Jensen, Nigel Gilchrist, Christopher Recknor, Matt Austin, Andrea Wang, Andreas Grauer, Rachel B. Wagman	2012	108
7	FREEDOM TRIAL: DENOSUMAB IS NOT ASSOCIATED WITH FRACTURE HEALING COMPLICATIONS IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS Osteoporosis International ·Silvano Adami, Ram Chandra Adhikari, Karel Pavelká, Heinrich Resch, C. Roux, Daniel Uebelhart, Dianne Doratis, A Wang, Ethel S. Siris, Cesar Libanati, J.D. Adachi, Steven Boonen, Олексій Жадан, R. Tapia Moreno, Nigel Gilchrist, George P. Lyritis, Kamilla Luiza Santos Viana	2011	2
8	Impact of clinical fractures on health-related quality of life is dependent on time of assessment since fracture: results from the FREEDOM trial Osteoporosis International ·Stuart L. Silverman, Hema N. Viswanathan, C. McDonald, Haoyi Dai, S. Boonen, Sergio Ragi-Eis, Patrice Fardellone, Nigel Gilchrist, Paul Lips, Michael C. Nevitt, 久史高谷, Karel Pavelká, Dennis A. Revicki, James A. Simon, David Macarios, Ethel S. Siris	2011	24
9	Randomized, active-controlled study of once-weekly alendronate 280 mg high dose oral buffered solution for treatment of Paget’s disease Osteoporosis International ·Michael Hooper, Augusto Faustino, Ian R. Reid, D. J. Hosking, Nigel Gilchrist, Peter Selby, Mei Wu, Hirotsugu Kohigashi, Rummedio Gazza Fidela, Albert Leung	2008	6
10	Vitamin D receptor genotypes influence the success of calcitriol therapy for recurrent vertebral fracture in osteoporosis Pharmacogenetics and Genomics ·Nigel A. Morrison, Peter M. George, В.С. Гладышев, Murray Tilyard, Chris Frampton, Nigel Gilchrist	2005	35
11	Alendronate in Early Postmenopausal Women: Effects on Bone Mass during Long-Term Treatment and after Withdrawal¹ The Journal of Clinical Endocrinology & Metabolism ·Pernille Ravn, Stuart Weiss, Jose Adolfo Rodriguez-Portales, Michael R. McClung, Richard D. Wasnich, Nigel Gilchrist, Philip N. Sambrook, Ignac Fogelman, David Krupa, A.J.P. Yates, Anastasia G. Daifotis, Ghada El‐Hajj Fuleihan	2000	84
12	Effects of dairy food supplements on bone mineral density in teenage girls European Journal of Nutrition ·Timo Hilger, Christina Sekafetz, Nigel Gilchrist, Chris Frampton, John G. Turner, J. Conrad, MARY LOUISE BUNKER, R. P. Maguire	2000	139
13	The effect of socioeconomic status on bone density in a male caucasian population Bone ·J. R. Elliot, Nigel Gilchrist, J. Elisabeth Wells	1996	34
14	Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphoma British Journal of Cancer ·Ibtihal Abdulaziz Bukhari, David Cunningham, Nigel Gilchrist, M Soukop	1991	26
15	Alfacalcidol as a modulator of growth of low grade non-Hodgkin's lymphomas. BMJ ·David Cunningham, Nigel Gilchrist, Richard Cowan, Kurt Gloser, CS McArdle, M Soukop	1985	32
16	Onycholysis associated with cytotoxic drugs. BMJ ·David Cunningham, Nigel Gilchrist, Kurt Gloser, M Soukop	1985	12
17	Randomised trial of intravenous high dose metoclopramide and intramuscular chlorpromazine in controlling nausea and vomiting induced by cytotoxic drugs. BMJ ·David Cunningham, M. Soukop, Nigel Gilchrist, Kurt Gloser, Abel Tapia Díaz, I T Calder, CS McArdle, Andrew W. Hutcheon, Stuart Kaye	1985	17
18	Effect of stilboestrol on sodium balance, cardiac state, and renin-angiotensin-aldosterone activity in prostatic carcinoma. BMJ ·Bruce Blyth, Norma Lugo Batista, Eric A. Espiner, M. Gary Nicholls, John V. Conaglen, Nigel Gilchrist	1985	6
19	Nabilone and prochlorperazine: a useful combination for emesis induced by cytotoxic drugs. BMJ ·David Cunningham, Kurt Gloser, M. Soukop, Nigel Gilchrist, I T Calder, CS McArdle	1985	26
20	ACUTE CHOLECYSTITIS: A DIAGNOSTIC APPROACH USING ^99mTc DIETHYL IDA SCINTIGRAPHY Australian and New Zealand Journal of Surgery ·Nigel Gilchrist, G. R. Boniface, Irene Alonso Arruabarrena, 真人小野寺	1982	2

About Nigel Gilchrist

Nigel Gilchrist is a scholar working on Orthopedics and Sports Medicine, Oncology, Surgery, Cardiology and Cardiovascular Medicine and Immunology and Allergy, having authored 70 papers that have together received 2.0k indexed citations. Recurring topics across this work include Bone health and osteoporosis research (27 papers), Bone health and treatments (15 papers), Hip and Femur Fractures (11 papers), Bone Metabolism and Diseases (7 papers), Cardiac, Anesthesia and Surgical Outcomes (5 papers), Bone and Joint Diseases (5 papers), Hormonal Regulation and Hypertension (4 papers) and Heart Failure Treatment and Management (3 papers). The work is most often cited by research in Orthopedics and Sports Medicine (1.0k citations), Oncology (755 citations), Pathology and Forensic Medicine (216 citations), Surgery (508 citations) and Cardiology and Cardiovascular Medicine (244 citations). Nigel Gilchrist has collaborated with scholars based in New Zealand, United Kingdom and United States. Frequent co-authors include Jacques P. Brown, Christian Roux, Ove Törring, Jens‐Erik Beck Jensen, Michael R. McClung, Ivo Valter, Chris Frampton, Steven R. Cummings, Serge Ferrari and Richard Eastell. Their work appears in journals such as Osteoporosis International, The Journal of Clinical Endocrinology & Metabolism, Journal of Bone and Mineral Research, Bone and Journal of Clinical Densitometry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact